Quantcast

Latest Pemetrexed Stories

2013-12-14 23:01:48

Scientists in Italy say vinorelbine may be a promising option for patients whose cancer returns after chemotherapy. Raleigh, NC (PRWEB) December 14, 2013 The anti-mitotic drug vinorelbine may be a safe and effective treatment for mesothelioma patients whose cancer progresses after first-line chemotherapy with the standard drugs. Pemetrexed (Alimta) is the primary first-line chemotherapy drug for mesothelioma patients with unresectable disease. The drug is usually paired with a...

2013-12-10 23:27:00

Turkish researchers say a new drug may make a standard chemotherapy drug more effective – and less toxic – for patients fighting malignant mesothelioma. Raleigh, NC (PRWEB) December 10, 2013 Surviving Mesothelioma is reporting on a promising new drug study published in Genetic and Molecular Research. The study suggests that panobinostat, an experimental drug developed by Novartis, may improve the effectiveness of cisplatin, one of the most common drugs used to treat mesothelioma....

2013-11-15 23:24:09

A combination of lung-sparing surgery and high-dose radiation may offer a "concrete therapeutic approach" to this hard-to-treat cancer. Raleigh, NC (PRWEB) November 15, 2013 Surviving Mesothelioma is reporting that medical researchers in Italy have achieved some of the best mesothelioma survival results seen in recent years using a combination approach that includes surgery, chemotherapy, and high-dose radiotherapy. Twenty patients with malignant pleural mesothelioma underwent...

2013-11-04 23:19:01

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022. London (PRWEB) November 04, 2013 PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch...

2013-11-04 23:04:31

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - UK Drug Forecast and Market Analysis to 2022. London (PRWEB) November 04, 2013 PharmaPoint: Non-Small Cell Lung Cancer - UK Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of...

2013-10-28 23:27:45

Australian scientists say altering the way cells express genes may give doctors a new way to combat malignant pleural mesothelioma. Raleigh, NC (PRWEB) October 28, 2013 In a study published in the Annals of Oncology and reported by Surviving Mesothelioma, researchers at the renowned Asbestos Diseases Research Institute in Sydney tested the role of microRNAs in mice with mesothelioma. MicroRNAs are tiny cell components responsible for the expression of a wide variety of genes, including...

2013-10-16 23:23:56

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - China Drug Forecast and Market Analysis to 2022. London (PRWEB) October 16, 2013 PharmaPoint: Non-Small Cell Lung Cancer - China Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch...

2013-10-03 23:22:52

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - US Drug Forecast and Market Analysis to 2022. London (PRWEB) October 03, 2013 PharmaPoint: Non-Small Cell Lung Cancer - US Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of...

2013-09-14 23:03:32

Researchers in The Netherlands say the most popular drug for malignant pleural mesothelioma may not be the most cost-effective drug for the job. Raleigh, NC (PRWEB) September 14, 2013 In a paper published in Anticancer Research and reported by Surviving Mesothelioma, an Amsterdam-based research team reviewed the medical literature on pemetrexed (Alimta), the first FDA-approved drug for mesothelioma, as well as other newer drugs and drug combinations. Although all of the anti-cancer agents...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related